You searched for "clinic"

723 results found

Transurethral en bloc resection versus standard resection of bladder tumour

Bladder cancer is a common urological malignancy, with around 610,000 new cases and 220,000 deaths worldwide in 2022. Approximately 75% of these cases are non-muscle-invasive bladder cancer (NMIBC). The conventional method for treating NMIBC is standard resection (SR), performed transurethrally,...

HOLEP and detrusor underactivity

Lower urinary tract symptoms (LUTS) are common among adult males, significantly influence quality of life (QoL) and contribute to pressure on the NHS. LUTS are conventionally associated with benign prostatic obstruction (BPO), which is commonly observed during the histological progression...

Adjustable Transobturator Male System® as a novel treatment for men with stress urinary incontinence

Stress urinary incontinence (SUI) in men is a debilitating condition, often occurring after prostate cancer surgery, with an incidence ranging from 4% to 40%. Key predictors of SUI post-prostatectomy include age, body mass index (BMI), comorbidity index, lower urinary tract...

Prevalence, diagnosis, and management of SUI in women

Stress urinary incontinence (SUI) is a widespread condition characterised by involuntary urine leakage triggered by physical activities such as coughing, sneezing, laughing, or exercise. Despite significantly impacting the quality of life (QoL), SUI remains underdiagnosed and undertreated, creating a substantial...

Action Bladder Cancer UK – 2019 Report

ABC UK is a national charity working for bladder cancer patients. Set up in 2009 we work to raise awareness of bladder cancer and the issues faced by patients; we provide direct support for patients; we work to improve outcomes for...

Action Bladder Cancer UK launches learning module for primary care

Action Bladder Cancer UK has launched a new online learning module for primary care, to help healthcare professionals improve their knowledge of bladder cancer. Bladder cancer is not a rare cancer. In the UK alone, over 23,000 people are diagnosed...

IBSA UK&I assumes direct commercial responsibility for ialuril® in the UK and Ireland

Transition supports continuity of supply and aligns ialuril® with IBSA’s expanding UK uro-gynaecology portfolio. Watford, UK – IBSA UK&I, the UK subsidiary of Swiss pharmaceutical company IBSA, today announces that it will assume direct responsibility for the commercialisation and distribution...

ERIC Conference, Together for 35 years: leading change in paediatric bowel and bladder health

ERIC, The Children’s Bowel & Bladder Charity, are back with their biennial conference. Healthcare professionals can expect talks on cutting-edge research, interactive workshops, practical demonstrations and much more. ERIC’s 2026 conference is a chance for professionals across the field of...

New survey explores the everyday impact of living with BPE

Prostate Scotland has launched a new national survey exploring the everyday impact of living with benign prostatic enlargement (BPE). It aims to build one of the clearest pictures to date of what it's really like to live with BPE in...

BAUS Annual Meeting 2024

Welcome from the Honorary Secretary I am thrilled to extend a warm welcome to each and every one of you as we gear up for what promises to be an enriching and enlightening conference experience. On behalf of Mo Belal,...

New patient survey highlights significant unmet need among long-term male catheter users

62% of 172 UK catheter users surveyed say they wish they had another option, rising to 71% among Foley/indwelling catheter users A new patient-reported survey adds to a growing body of evidence that long-term catheter use carries a substantial and...

In conversation with Rebecca Porta

We were delighted to chat to Rebecca Porta, the new Chief Executive of The Urology Foundation (TUF) First of all, many congratulations on your recent appointment as Chief Executive of TUF; can you tell us a little bit about your...